Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$52,028,079
+$18,017,428 QoQ
Shares Held
206,756
+32.2% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#353
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $371,290,075 across 10 Drug Manufacturers - General names. ABBV ranks #3 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,318 | $108,330,127 | |
| 2 | JNJ |
Johnson & Johnson
|
265,811 | $67,508,019 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
206,756 | $52,028,079 | |
| 4 | AMGN |
Amgen Inc
|
109,431 | $39,627,153 | |
| 5 | MRK |
Merck & Co., Inc.
|
273,534 | $35,149,119 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
264,468 | $33,412,887 | |
| 7 | PFE |
Pfizer Inc
|
635,140 | $15,294,171 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
228,360 | $13,158,103 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,028,079 | 206,756 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $34,010,651 | 156,378 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $49,380,801 | 216,118 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $54,210,460 | 234,130 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $43,975,976 | 236,914 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $44,927,164 | 214,429 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $49,291,492 | 277,386 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $52,597,613 | 266,344 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $51,797,496 | 301,991 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $42,518,346 | 233,489 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $37,173,273 | 239,874 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $36,359,162 | 243,923 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $31,088,947 | 230,750 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $32,452,353 | 203,629 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $32,583,161 | 201,616 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $19,281,816 | 143,669 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,655,800 | 69,573 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $14,576,282 | 89,916 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $13,736,736 | 101,453 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $9,228,602 | 85,553 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $6,663,669 | 59,159 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $7,011,790 | 64,792 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $4,129,882 | 38,543 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,772,954 | 54,492 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,234,859 | 53,319 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,452,486 | 19,064 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||